Abbott Laboratories
ABT
Company Profile
Business description
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Contact
100 Abbott Park Road
Abbott ParkIL60064-6400
USAT: +1 224 667-6100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2024
Employees
114,000
Stocks News & Analysis
stocks
Tesla: Trump election may solidify near-term Tesla US EV leadership
Do possible benefits from the election make shares attractive?
stocks
ASX players that might thrive under a Trump administration
Recent election results have sent US markets into a record-high rally however implications remain mixed for the Australian share market. See our top ASX picks that could do better under a second Trump administration.
stocks
3 "buy the dip" candidates with wide moats
Share price pullbacks can present an opportunity to buy high quality companies at attractive prices.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,450.90 | 64.30 | -0.76% |
| CAC 40 | 7,216.83 | 10.15 | -0.14% |
| DAX 40 | 19,003.11 | 30.53 | -0.16% |
| Dow JONES (US) | 43,958.19 | 47.21 | 0.11% |
| FTSE 100 | 8,030.33 | 4.56 | 0.06% |
| HKSE | 19,823.45 | 23.43 | -0.12% |
| NASDAQ | 19,230.72 | 50.68 | -0.26% |
| Nikkei 225 | 38,721.66 | 654.43 | -1.66% |
| NZX 50 Index | 12,613.30 | 61.19 | -0.48% |
| S&P 500 | 5,985.38 | 1.39 | 0.02% |
| S&P/ASX 200 | 8,193.40 | 62.20 | -0.75% |
| SSE Composite Index | 3,439.28 | 17.31 | 0.51% |